WO2024217724 - PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND METHOD FOR THE PREPARATION THEREOF
National phase entry:
Publication Number
WO/2024/217724
Publication Date
24.10.2024
International Application No.
PCT/EP2024/025148
International Filing Date
15.04.2024
Title **
[English]
PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND METHOD FOR THE PREPARATION THEREOF
[French]
COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGENT ANTIMICROBIEN ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
PHARMATHEN S.A.
Inventors
KARAVAS, Evangelos
KOUTRIS, Efthymios
SAMARA, Vasiliki
KOUTRI, Ioanna
KALASKANI, Anastasia
FOUSTERIS, Manolis
DRAGANOUDI, Christina
Priority Data
20230100332
20.04.2023
GR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1872 | |
| EPO | Filing, Examination, Granting | 6211 | |
| Japan | Filing, Examination, Granting | 1961 | |
| South Korea | Filing, Examination, Granting | 1600 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
16,384
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a stable pharmaceutical formulation of solid dosage forms for oral administration comprising an antimicrobial agent such as Rifaximin or a pharmaceutical acceptable salt, derivative or polymorph thereof as the active ingredient. It also relates to an innovative process for the preparation thereof.[French]
La présente invention concerne une formulation pharmaceutique stable de formes posologiques solides pour administration orale comprenant un agent antimicrobien tel que la rifaximine ou un sel, un dérivé ou un polymorphe pharmaceutiquement acceptable de celui-ci en tant que principe actif. L'invention concerne également un procédé innovant pour la préparation de celui-ci.